Skip to site content

Medication Therapy

img-description
Session Title Session Material CME/CE Information
New Diabetes Update: Roles and Benefits of SGLT-2 Inhibitors and GLP-1 Agonists Exit Disclaimer: You Are Leaving www.ihs.gov 
Paul Bloomquist, MD
Area Diabetes Consultant
Phoenix Area IHS

(Originally presented on 09/21/21.)
New Pharmacovigilance: Timely Information Regarding Medication Safety Exit Disclaimer: You Are Leaving www.ihs.gov 
Chris Lamer, PharmD, MHS, BCPS, CDE
Director, Pharmacovigilance
IHS National Pharmacy and Therapeutics Committee

(Originally presented on 12/9/20.)